Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.

Schizophrenia bulletin - 1 Jul 2013

Simons Claudia J P, van Winkel Ruud

Abstract excerpt

Psychotic disorders are associated with neurocognitive alterations that aggregate in unaffected family members, suggesting that genetic vulnerability to psychotic disorder impacts neurocognition. The aim of the present study was to investigate whether selected schizophrenia candidate single nucle...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cognition Disorders
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Psychotic Disorders

Share to Siblings

Share to Vesicular Monoamine Transport Proteins

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 22532702
DOI: 10.1093/schbul/sbs067
PMCID: PMC3686448

Genes

BDNF
DRD1
DRD3
FGF2
FKBP5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22532702-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.PMID 22532702Read ↗

Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.Semantic proximity Read ↗

Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance.Semantic proximity Read ↗

The Role of SLC39A8.p.(Ala391Thr) in Schizophrenia Symptom Severity and Cognitive Ability: Cross-Sectional Studies of Schizophrenia and the General UK Population.Semantic proximity Read ↗

Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.Semantic proximity Read ↗

Genetic mechanisms of psychosis: in vivo and postmortem genomics.Semantic proximity Read ↗

Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia.Semantic proximity Read ↗

Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes.Semantic proximity Read ↗

Genome-wide association study of Alzheimer's disease with psychotic symptoms.Semantic proximity Read ↗

Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample.Semantic proximity Read ↗

Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.Semantic proximity Read ↗

Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.Semantic proximity Read ↗

Ultrarare Coding Variants and Cognitive Function in Schizophrenia-Unraveling the Enduring Mysteries of Neuropsychiatric Genetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.